| Autor: |
Gowtham R. Grandhi, MD MPH, Rishav Adhikari, MD, Erfan Tasdighi, MD, Albert D. Osei, MD MPH, Michael Khorsandi, MD, Anurag Mehta, MD, Michael Blaha, MD MPH |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100572- (2023) |
| Druh dokumentu: |
article |
| ISSN: |
2666-6677 |
| DOI: |
10.1016/j.ajpc.2023.100572 |
| Popis: |
Therapeutic Area: Heart Failure Background: Several studies have shown that most patients who are eligible for an Sodium-glucose Cotransporter-2 inhibitor (SGLT2i) are not receiving them and the proportion of prescriptions from cardiologists was very low ( |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
